Back to search

Belgium· BE-AMP-SAM598995-00

Kapruvia 50 µg/ml

A difelikefalin product containing difelikefalin acetate, registered in Belgium by Vifor Fresenius Medical Care Renal Pharma France. The same ATC class is registered in 14 of our 19 countries.

ATC V03AX04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedKapruvia 50 µg/mlATCV03AX04REGISTER NO.BE-AMP-SAM598995-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Difelikefalin is registered in 14 of 19 countries.

Countries holding a registration under ATC V03AX04 (difelikefalin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Difelikefalin · ATC V03AX04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Difelikefalin Acetate
Manufacturer
Vifor Fresenius Medical Care Renal Pharma France
Country
Belgium (BE)
ATC code
V03AX04
ATC class
Difelikefalin
Defined daily dose
15 mcg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    4801858

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c946ade1-7860-48c6-80cb-1b1eb5e8315f
GET /v1/drugs/c946ade1-7860-48c6-80cb-1b1eb5e8315f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Kapruvia 50 µg/ml",
  "name_fr": "Kapruvia 50 µg/ml",
  "name_nl": "Kapruvia 50 µg/ml",
  "amp_code": "SAM598995-00",
  "strengths": [
    "50.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Difelikefalin Acetate",
    "Difelikefalin",
    "Sodium Acetate Trihydrate",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Difelikefalin",
  "authorisation_numbers": [
    "EU/1/22/1643/001",
    "EU/1/22/1643/002"
  ]
}

See everything about difelikefalin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.